These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22574160)

  • 21. Pegylated peptides. IV. Enhanced biological activity of site-directed pegylated GRF analogs.
    Felix AM; Lu YA; Campbell RM
    Int J Pept Protein Res; 1995; 46(3-4):253-64. PubMed ID: 8537179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solid-phase polyethylene glycol conjugation using hydrophobic interaction chromatography.
    Niu J; Zhu Y; Xie Y; Song L; Shi L; Lan J; Liu B; Li X; Huang Z
    J Chromatogr A; 2014 Jan; 1327():66-72. PubMed ID: 24411087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced circulating half-life and antitumor activity of a site-specific pegylated interferon-alpha protein therapeutic.
    Bell SJ; Fam CM; Chlipala EA; Carlson SJ; Lee JI; Rosendahl MS; Doherty DH; Cox GN
    Bioconjug Chem; 2008 Jan; 19(1):299-305. PubMed ID: 18020402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-Based Site-Specific PEGylation of Fibroblast Growth Factor 2 Facilitates Rational Selection of Conjugate Sites.
    Zhao J; Li Q; Wu J; Zhou C; Cao Y; Li X; Niu J
    Biotechnol J; 2020 Feb; 15(2):e1900203. PubMed ID: 31556248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategies to suppress aggregation of recombinant keratinocyte growth factor during liquid formulation development.
    Chen BL; Arakawa T; Hsu E; Narhi LO; Tressel TJ; Chien SL
    J Pharm Sci; 1994 Dec; 83(12):1657-61. PubMed ID: 7891291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A solid-phase PEGylation strategy for protein therapeutics using a potent FGF21 analog.
    Song L; Zhu Y; Wang H; Belov AA; Niu J; Shi L; Xie Y; Ye C; Li X; Huang Z
    Biomaterials; 2014 Jun; 35(19):5206-15. PubMed ID: 24685265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of keratinocyte growth factor on clonal growth of epithelial tumor cells, lymphoma and leukemia cells and on sensitivity of tumor cells towards 5-fluorouracil in vitro.
    Oelmann E; Haghgu S; Kulimova E; Mesters RM; Kienast J; Herbst H; Schmitmann C; Kolkmeyer A; Serve H; Berdel WE
    Int J Oncol; 2004 Oct; 25(4):1001-12. PubMed ID: 15375550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In silico analysis of different signal peptides for the secretory production of recombinant human keratinocyte growth factor in Escherichia coli.
    Dastjerdeh MS; Marashiyan M; Boroujeni MB; Golkar M; Shokrgozar MA; Rahimi H
    Comput Biol Chem; 2019 Jun; 80():225-233. PubMed ID: 30999249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rational Design and Production of Bioactive Analogs of Recombinant Human Keratinocyte Growth Factor (rhKGF) with Reduced Aggregation Propensity.
    Dastjerdeh MS; Yasami-Khiabani S; Boroujeni MB; Shokrgozar M; Aliabadi HAM; Golkar M; Rahimi H
    Protein J; 2023 Feb; 42(1):37-54. PubMed ID: 36683078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure, biology, and therapeutic implications of pegylated interferon alpha-2b.
    Youngster S; Wang YS; Grace M; Bausch J; Bordens R; Wyss DF
    Curr Pharm Des; 2002; 8(24):2139-57. PubMed ID: 12369859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Precise and combinatorial PEGylation generates a low-immunogenic and stable form of human growth hormone.
    Wu L; Chen J; Wu Y; Zhang B; Cai X; Zhang Z; Wang Y; Si L; Xu H; Zheng Y; Zhang C; Liang C; Li J; Zhang L; Zhang Q; Zhou D
    J Control Release; 2017 Mar; 249():84-93. PubMed ID: 28131652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One-step production of bioactive proteins through simultaneous PEGylation and refolding.
    Niu J; Zhu Y; Song L; Xie Y; Zhang Y; Wang H; Li X; Liu B; Cai L; Huang Z
    Bioconjug Chem; 2014 Jan; 25(1):63-71. PubMed ID: 24341776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, modeling, expression, and chemoselective PEGylation of a new nanosize cysteine analog of erythropoietin.
    Cohan RA; Madadkar-Sobhani A; Khanahmad H; Roohvand F; Aghasadeghi MR; Hedayati MH; Barghi Z; Ardestani MS; Inanlou DN; Norouzian D
    Int J Nanomedicine; 2011; 6():1217-27. PubMed ID: 21753873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Keratinocyte growth factor induces vascular endothelial growth factor-A expression in colorectal cancer cells.
    Narita K; Fujii T; Ishiwata T; Yamamoto T; Kawamoto Y; Kawahara K; Nakazawa N; Naito Z
    Int J Oncol; 2009 Feb; 34(2):355-60. PubMed ID: 19148469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PEGylation prevents the N-terminal degradation of megakaryocyte growth and development factor.
    Guerra PI; Acklin C; Kosky AA; Davis JM; Treuheit MJ; Brems DN
    Pharm Res; 1998 Dec; 15(12):1822-7. PubMed ID: 9892464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical and Enzymatic Site Specific PEGylation of hGH: The Stability and in vivo Activity of PEG-N-Terminal-hGH and PEG-Gln141-hGH Conjugates.
    Grigoletto A; Mero A; Zanusso I; Schiavon O; Pasut G
    Macromol Biosci; 2016 Jan; 16(1):50-6. PubMed ID: 26350165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemical and enzymatic site specific PEGylation of hGH.
    da Silva Freitas D; Mero A; Pasut G
    Bioconjug Chem; 2013 Mar; 24(3):456-63. PubMed ID: 23432141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Site-specific PEGylation for high-yield preparation of Lys(21)-amine PEGylated growth hormone-releasing factor (GRF) (1-29) using a GRF(1-29) derivative FMOC-protected at Tyr(1) and Lys(12).
    Youn YS; Lee KC
    Bioconjug Chem; 2007; 18(2):500-6. PubMed ID: 17243755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-terminal specificity of PEGylation of human bone morphogenetic protein-2 at acidic pH.
    Hu J; Sebald W
    Int J Pharm; 2011 Jul; 413(1-2):140-6. PubMed ID: 21539904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Keratinocyte growth factor stimulates growth of MIA PaCa-2 cells through extracellular signal-regulated kinase phosphorylation.
    Yamamoto T; Matsuda Y; Kawahara K; Naito Z; Ishiwata T
    Oncol Lett; 2012 Feb; 3(2):307-310. PubMed ID: 22740901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.